FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Cellebrite DI Ltd. Stock AnalysisComprehensive stock analysis for Cellebrite DI Ltd. (CLBTW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCLBTW
CLBTW
Cellebrite DI Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CLBTW
Home🔹Stocks🔹Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBTW•NASDAQ

Cellebrite DI Ltd.

CLBTW•NASDAQ
Market cap
$1.09B
Sentiment

Your view on CLBTW

Mkt Cap
$1.09B
Sentiment
Your view
CLBTW
Cellebrite DI Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CLBTW
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cellebrite DI Ltd.

Industry
Software - Infrastructure
Sector
Technology
CEO
Yossi Carmil
Headquarters
94 Shlomo Shmelzer Road, Petah Tikva, IL
Industry
Software - Infrastructure
Sector
Technology
CEO
Yossi Carmil
Headquarters
94 Shlomo Shmelzer Road, Petah Tikva, IL
Description

Cellebrite DI Ltd., established in 1999 and headquartered in Petah Tikva, Israel, delivers comprehensive digital intelligence solutions for authorized investigations worldwide, spanning Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's core offering, the DI suite, enables investigators to effectively collect, scrutinize, analyze, and manage digital evidence throughout the entire investigative lifecycle. These robust tools are deployed across a broad spectrum of critical cases, including child exploitation, homicide, anti-terrorism efforts, border security, sexual assault, human trafficking, corporate security breaches, cryptocurrency investigations, and intellectual property theft. Key products within their portfolio include Inseyets, a digital forensics software that facilitates the collection and review of digital evidence from various sources, offering advanced data extraction, decoding, workflow streamlining, and automation features. To expedite the investigative process, Cellebrite Pathfinder automates the analysis and visualization of digital evidence, substantially reducing manual review time. The Smart Search tool helps gather and examine publicly accessible online information automatically, while Guardian serves as a dedicated solution for managing cases and evidence. Beyond these, Cellebrite provides specialized software for enterprises and service providers, such as Inseyets for Enterprise, Endpoint Inspector, and Mobile Now. The company also offers essential professional services, including training and certification programs. Its primary clientele consists of federal, state, and local government agencies.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

FRC's fair value estimate for Cellebrite DI Ltd., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Cellebrite DI Ltd.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Cellebrite DI Ltd.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Cellebrite DI Ltd.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Cellebrite DI Ltd.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Cellebrite DI Ltd. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold Cellebrite DI Ltd., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by Cellebrite DI Ltd. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Cellebrite DI Ltd.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Cellebrite DI Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Cellebrite DI Ltd.. Press releases and market coverage, newest first.

News

Latest Market News